British Columbia, Canada-based Tilray is recalling new batches of medical cannabis extracts in Germany because of incorrect THC content, German independent pharmaceutical newspaper DAZ reported. It is the second product recall for Tilray this summer. According to DAZ, Tilray recalled a total of six batches, all of the same product: THC10:CBD10. The extract is a 25 […]
More Tilray product recalls in Germany, report says is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: More Tilray product recalls in Germany, report says

Comments are closed, but trackbacks and pingbacks are open.